R&D,Bioinformatics,AI & ML,News

Uses for AI in Pharma R&D

4 weeks ago By Josh Neil
  • Share on

  • Facebook
  • Linkedin

AI is by far the biggest buzzword in pharma today – but unlike many other high-profile trends, AI has the potential to rapidly and totally transform the sector forever, speeding up processes, automating basic tasks and making sense of the huge data stockpiles pharma companies are dealing with. Nowhere is this more evident than in R&D, where vast data sets must be stored, formatted and analysed rapidly and the effects of potential treatments must be known.

To clarify the area for professionals who need to know, Proventa International created a White Paper on AI in R&D, looking at the innovations and trends shaping 2020, expert opinion on AI’s impact on R&D, and whether AI can reverse the steady decline in pharma R&D output. Below is just a sample of the full White Paper: to read the larger report, click here.

If you are unable to see the PDF below, please click here.

Joshua Neil, Editor
Proventa International

More news

How will COVID-19 Change Biomanufacturing?

The COVID-19 pandemic proved how ill-equipped the world was for a virus of that scale and potency. In the first months of the pandemic, businesses across all sectors scrambled to prepare their processes and supply chains for the coming disruption,...

2 weeks ago
R&D,Bioinformatics,AI & ML,News

How will COVID-19 Change Biomanufacturing?

The COVID-19 pandemic proved how ill-equipped the world was for a virus of that scale and potency. In the first months of the pandemic, businesses across all sectors scrambled to prepare their processes and supply chains for the coming disruption,...

2 weeks ago

Overcoming the Challenges of Decentralised Trials

Decentralised trials - clinical trials with virtual or online elements - have a huge number of advantages in the trial space. They are cheaper, faster, and allow for greater safety and recruitment of patients. But so far they have yet...

4 weeks ago
R&D,Bioinformatics,AI & ML,News

Overcoming the Challenges of Decentralised Trials

Decentralised trials - clinical trials with virtual or online elements - have a huge number of advantages in the trial space. They are cheaper, faster, and allow for greater safety and recruitment of patients. But so far they have yet...

4 weeks ago

Why the Decline in Pharma R&D?

For a few decades now there has been a narrative in the pharmaceutical sector that R&D productivity has been steadily declining: thanks to a lack of low-hanging fruit, blockbuster drugs have been harder and harder to find. AI promises a...

4 weeks ago
R&D,Bioinformatics,AI & ML,News

Why the Decline in Pharma R&D?

For a few decades now there has been a narrative in the pharmaceutical sector that R&D productivity has been steadily declining: thanks to a lack of low-hanging fruit, blockbuster drugs have been harder and harder to find. AI promises a...

4 weeks ago
Working With us

Interested?
Reserve your space